INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Integrated Single-Site CDMO Model

  A single‑site model reduces handoff risks, speeds timelines, strengthens quality oversight, and unifies development and manufacturing to improve reliability and execution efficiency.

• How To Select The Right Fill-Finish CDMO For Phase I–II

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

• Performance Of Mobius® Bag Assemblies With Ultimus® Film In Truck Shipping Simulation Test

  Explore findings from a study testing Mobius® single-use bags under rigorous shipping conditions, demonstrating the suitability for transporting various liquid volumes while preserving their integrity.

• GLP-1 INJ Solid Phase Peptide Synthesis (SPPS) Workflow

  Scale your GLP-1 peptide synthesis efficiently. Discover how automated solid-phase workflows and single-use fluidics maximize crude purity while reducing total solvent consumption.

• Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

  10/24/2024

  Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

• From LAL To rFC: The Evolution Of Endotoxin Testing

  6/26/2026

  Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.

• Scaling For Success: Preparing Your Cell Culture Workflow

  7/21/2025

  Uncover how early planning of medium, feed systems, and manufacturing workflow can mitigate costs, reduce delays, and accelerate therapeutic delivery to patients.

• Demonstrating Technical Excellence In Contract Manufacturing

  12/10/2024

  Tech Talks explore ADC development innovations, including integrated supply chains, seamless pilot-to-GMP scale-ups, and advanced process analytical technology (PAT).

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.